Discounting and health benefits
- PMID: 1342633
- DOI: 10.1002/hec.4730010110
Discounting and health benefits
Abstract
This paper argues that non-monetary health benefits should not be discounted at the same rate as variables expressed in monetary terms. It argues instead that the appropriate discount rate should be at or close to zero. It explores the various influences of rising income, age and pure time preference on the relative value of current and future health states. It examines various arguments advanced to justify the current practice of discounting health benefits at the same rate as monetary costs. These include uncertainty and delay. The article concludes with an analysis of the likely impact of adopting a zero discount rate on the ranking of health interventions.
Comment in
-
Discounting and health benefits: another perspective.Health Econ. 1992 Apr;1(1):76-9. doi: 10.1002/hec.4730010111. Health Econ. 1992. PMID: 1342634
Similar articles
-
Discounting and health benefits: another perspective.Health Econ. 1992 Apr;1(1):76-9. doi: 10.1002/hec.4730010111. Health Econ. 1992. PMID: 1342634
-
Valuing future benefits.Health Econ. 1994 Jul-Aug;3(4):221-9. doi: 10.1002/hec.4730030404. Health Econ. 1994. PMID: 7994322
-
Rationing alternatives for medical care.Annu Rev Public Health. 1994;15:413-36. doi: 10.1146/annurev.pu.15.050194.002213. Annu Rev Public Health. 1994. PMID: 8054093 Review. No abstract available.
-
Discounting in health care decision-making: time for a change?J Public Health Med. 1992 Sep;14(3):250-6. J Public Health Med. 1992. PMID: 1419202
-
Rationing in the NHS: the dance of the seven veils-in reverse.Br Med Bull. 1995 Oct;51(4):769-80. doi: 10.1093/oxfordjournals.bmb.a072992. Br Med Bull. 1995. PMID: 8556286 Review.
Cited by
-
Cost savings associated with detection and treatment of diabetic eye disease.Pharmacoeconomics. 1995;8 Suppl 1:33-9. doi: 10.2165/00019053-199500081-00008. Pharmacoeconomics. 1995. PMID: 10159001
-
The marginal benefits of healthcare spending in the Netherlands: Estimating cost-effectiveness thresholds using a translog production function.Health Econ. 2019 Nov;28(11):1331-1344. doi: 10.1002/hec.3946. Epub 2019 Aug 30. Health Econ. 2019. PMID: 31469510 Free PMC article.
-
Economic evaluations of varicella vaccination programmes: a review of the literature.Pharmacoeconomics. 2003;21(1):13-38. doi: 10.2165/00019053-200321010-00002. Pharmacoeconomics. 2003. PMID: 12484801 Review.
-
Perspective and desire in comparative effectiveness research: the relative unimportance of mere preferences, the central importance of context.Pharmacoeconomics. 2010;28(10):889-97. doi: 10.2165/11535270-000000000-00000. Pharmacoeconomics. 2010. PMID: 20831296
-
Hepatic resection for colorectal liver metastases: A cost-effectiveness analysis.Ann Surg. 2000 Dec;232(6):763-76. doi: 10.1097/00000658-200012000-00005. Ann Surg. 2000. PMID: 11088071 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources